- Lilly reports second-quarter 2025 financial results and raises guidance Eli Lilly and Company
- Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar CNBC
- Eli Lilly beats earnings for second quarter on strong GLP-1 sales, but stock dives on GLP-1 pill trial results Yahoo Finance
- Eli Lilly Reports Earnings, and Maybe Weight-Loss Pill Data, on Thursday Barron’s
- Eli Lilly raises full-year profit forecast on weight-loss drug strength MSN
Source link
